Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
osTEAo: Long Term Side Effects from Treatment For Osteosarcoma and AYA Cancer
|
May 15, 2024 |
Creating a translational genomic framework for canine osteosarcoma: updates on the NCI DOG2 project
|
May 10, 2024 |
Positioning Poly-(ADP)-ribose polymerase inhibitors (PARPi) for the treatment of Osteosarcoma
|
May 03, 2024 |
TGF-beta inhibition as a novel therapeutic option in Osteosarcoma
|
Apr 25, 2024 |
Out on a Limb - Travel Tips for AYA Cancer Patients
|
Apr 17, 2024 |
Phase 1 Study of Cabozantinib in Combination with Topotecan-Cyclophosphamide for Patients with Relapsed or Refractory Ewing Sarcoma or Osteosarcoma
|
Apr 11, 2024 |
Targeting Urea Cycle Dysfunction to Prevent and Treat Osteosarcoma Metastasis
|
Apr 05, 2024 |
osTEAo: Patient Experiences with Lung Surgery for Osteosarcoma
|
Mar 21, 2024 |
Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research
|
Mar 14, 2024 |
Patient perspectives on participating in research and clinical trials
|
Mar 08, 2024 |
Tissue Engineering Strategies for Elucidating Osteosarcoma Biology and Drug Discovery
|
Mar 01, 2024 |
Liquid biopsy in Ewing sarcoma and osteosarcoma as a prognostic and response diagnostic: The LEOPARD Study
|
Feb 23, 2024 |
Managing Stress in AYA Cancer Patients
|
Feb 15, 2024 |
Prevention of Cisplatin-induced Hearing Loss: Implications for Young People Treated for Osteosarcoma
|
Feb 09, 2024 |
TACOS: A Phase 2 Trial of Atezolizumab and Cabozantinib in OsteoSarcoma
|
Jan 26, 2024 |
osTEAo: Making friends after a cancer diagnosis
|
Jan 18, 2024 |
Interventions to promote physical function during and after treatment for osteosarcoma
|
Jan 11, 2024 |
The Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan (CAUSAL) study
|
Dec 15, 2023 |
Developing a Multiscale Transcriptional Atlas of Sarcoma
|
Dec 08, 2023 |
Immunological Mechanisms of Cancer Defense
|
Dec 01, 2023 |
osTEAo: Long Term Osteosarcoma Survivors: Where They Were and Where They Are Now
|
Nov 16, 2023 |
Cabozantinib as a Maintenance Therapy to Prevent Recurrence of High-Risk Pediatric Solid Tumors
|
Oct 27, 2023 |
osTEAo - Coping with Cancer through Music
|
Oct 19, 2023 |
OsteoBites Preguntas & Respuestas con Nino Rainusso, MD
|
Oct 13, 2023 |
TCF-001 TRACK (Target Rare Cancer Knowledge): A Clinical Trial Studying Precision Medicine in Rare Cancers
|
Oct 06, 2023 |
Repurposing Disulfiram to Overcome Chemotherapy Resistance in Relapsed Sarcomas
|
Sep 29, 2023 |
osTEAo Tea Spill: AYA Cancer Gab Sesh
|
Sep 20, 2023 |
Addressing the Unmet Scientific Challenges in Osteosarcoma Treatment through Innovative Engineering Techniques
|
Sep 15, 2023 |
Implementing Multi-Targeted Tyrosine Kinase Inhibitors in Combination with Chemotherapy for Osteosarcoma
|
Sep 01, 2023 |
Immune Therapies in EGFR-Expressing Cancers
|
Aug 25, 2023 |
OsTEAo - An Honest Q&A with Osteosarcoma AYA Patients, Survivors, and Siblings
|
Aug 17, 2023 |
Treatment of Osteosarcoma Using Smart Targeted Drug Delivery Nanoplatforms
|
Aug 11, 2023 |
MIB Agents and SARC: A Case Study in Collaboration
|
Aug 04, 2023 |
OSI Funded Work
|
Jul 28, 2023 |
OsTEAo - Survivor's Guilt and Grief with grief coach Lori Krause
|
Jul 20, 2023 |
Pretargeted Approach to Delivery of Radiopharmaceutical Therapy for Bone Cancer - a Click Chemistry Study in Canines with Osteosarcoma
|
Jul 14, 2023 |
osTEAo - Coping with Humor: A Review of Cancer Memes
|
Jun 15, 2023 |
The Importance of Patient-Powered Osteosarcoma Research: Count Me In
|
Jun 09, 2023 |
Osteosarcoma Organoid Models: The Potential and Limitations of Personalized Avatars
|
Jun 02, 2023 |
Reprogramming NK Cells Within the Tumor Microenvironment of Osteosarcoma Lung Metastases
|
May 26, 2023 |
osTEAo- Returning to Yourself: Confidence and Identity as an AYA Cancer Patient
|
May 18, 2023 |
OSI Connect: Osteosarcoma Answers and Assistance
|
May 12, 2023 |
Open Clinical Trial: GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
|
May 09, 2023 |
SCF-Skp2 Protein Complex as a Therapy for Osteosarcoma by Blocking the Mutational Effects of Rb and p53
|
Apr 28, 2023 |
osTEAo - Navigating Scanxiety
|
Apr 20, 2023 |
Cold Atmospheric Plasma: A New Therapeutical Option for Osteosarcoma?
|
Apr 14, 2023 |
UHRF1 Overexpression Promotes Osteosarcoma Metastasis through Altered Exosome Production and AMPK/SEMA3E Suppression
|
Mar 31, 2023 |
Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS) for Sarcoma
|
Mar 24, 2023 |
osTEAo - Navigating Campus: Limb-Salvage and Amputation Patient Perspectives
|
Mar 16, 2023 |
Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks
|
Mar 10, 2023 |
SarcoSIGHT- A Randomised Controlled Trial of Fluorescence Guided Sarcoma Surgery versus Standard Care
|
Mar 03, 2023 |
Virtual Surgical Planning and 3D Printing in Pediatric Musculoskeletal Oncological Resections
|
Feb 17, 2023 |
Two Epigenetically Distinct Cellular States in Osteo are Regulated by a State-Specific Set of Transcription Factors Driving Differential Drug Response
|
Jan 27, 2023 |
Clinical Trial: Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
|
Jan 13, 2023 |
Cell Based Therapies for Osteosarcoma
|
Dec 09, 2022 |
osTEAo Q&A with Dr. Kurt Weiss - What questions do you have about Osteosarcoma but are afraid to ask?
|
Nov 17, 2022 |
Interventional Radiology/HIFU Perspectives for Osteosarcoma
|
Nov 11, 2022 |
Focal Adhesion Kinase (FAK) Inhibition to Improve Losartan-Sunitinib Immunotherapy in Metastatic Osteosarcoma
|
Nov 04, 2022 |
Updates from Clinical Sequencing of 2,138 Bone and Soft Tissue Sarcomas
|
Oct 28, 2022 |
osTEAo Presents Halloween Spooky Stories
|
Oct 20, 2022 |
How Osteosarcoma Evolves from Diagnosis to Relapse
|
Oct 14, 2022 |
Transforming the Way Researchers Share Data: Lessons from the Pediatric Cancer Data Commons
|
Oct 07, 2022 |
osTEAo - Dating & Intimacy with Lauren Broschak, MSW, LCSW, OSW-C
|
Sep 22, 2022 |
Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma
|
Sep 16, 2022 |
Report on the Phase I/II Study of Single-Agent Lenvatinib in Children and Adolescents with Refractory or Relapsed Solid Malignancies and Young Adults with Osteosarcoma
|
Sep 09, 2022 |
Inhaled Recombinant Human IL-15 in Dogs with Naturally Occurring Pulmonary Metastases from Osteosarcoma or Melanoma: a Phase 1 Study
|
Sep 02, 2022 |
Outsmarting OS 2021 Funded Research Update: Exploring Aldehyde Dehydrogenase and Androgen Receptor Actions to OutSmart Osteosarcoma Metastases
|
Aug 26, 2022 |
Back to School: OsteoWarrior and OsteoSibling Perspectives
|
Aug 18, 2022 |
Combination Therapies to Improve Immune-Mediated Approaches for Osteosarcoma
|
Aug 12, 2022 |
Using RNA-Nanoparticle Vaccines to Overcome the Immunosuppressive Tumor Microenvironment of Canine Osteosarcoma
|
Aug 05, 2022 |
COG Project: Every Child - Episode Sponsored by Osteosarcoma Institute
|
Jul 30, 2022 |
Body Image for AYAs with Cancer with Dr. Lori Weiner
|
Jul 21, 2022 |
Unanswered Clinical Questions in Sarcoma: Opportunities to Move from Bedside to Bench - Episode Sponsored by Osteosarcoma Institute
|
Jul 15, 2022 |
Molecular Profiling Identifies Targeted Therapy Opportunities in Pediatric Solid Cancer - Episode Sponsored by Osteosarcoma Institute
|
Jul 10, 2022 |
Navigating Pediatric Cancer Clinical Trials
|
Jun 20, 2022 |
Update on OSI funded phase 2 Trial of Olaparib + Ceralasertib in Recurrent Osteosarcoma
|
Jun 10, 2022 |
Limb Salvage Surgery for OS: Patient & Surgeon Perspectives sponsored by the Osteosarcoma Institute
|
May 27, 2022 |
"Armored" CAR T cells for Osteosarcoma sponsored by BTG Specialty Pharmaceuticals
|
May 20, 2022 |
Immunotherapy for Osteosarcoma - Where Do We Go From Here? Sponsored by BTG Specialty Pharmaceuticals
|
May 13, 2022 |
The Osteosarcoma Project sponsored by BTG Specialty Pharmaceuticals
|
May 06, 2022 |
osTEAo Debut
|
Apr 29, 2022 |
Update on Clinical Trial Development Targeting Tumor Microenvironment in Refractory and Metastatic Osteosarcoma
|
Apr 22, 2022 |
Exploring the Use of a Predictive Tool for Methotrexate Clearance sponsored by BTG Specialty Pharmaceuticals
|
Apr 15, 2022 |
A Phase 1/2 Study of ZN-c3 Plus Gemcitabine in Relapsed or Refractory Osteosarcoma
|
Apr 15, 2022 |
MYC Amplification as a Prognostic Biomarker in Osteosarcoma Sponsored by BTG Speciality Pharmaceuticals
|
Apr 01, 2022 |
Compassionate Use of Investigational Drugs: A Strategy to Access Unapproved Therapies for Pediatric Oncology Patients Presented by BTG Speciality Pharmaceuticals
|
Mar 25, 2022 |
The Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) International Randomized Controlled Trial Sponsored by BTG Specialty Pharmaceuticals
|
Mar 18, 2022 |
Osteosarcoma Q&A with OsteoWarriors sponsored by BTG Specialty Pharmaceuticals
|
Mar 11, 2022 |
Truths & Myths of Nutrition in Cancer sponsored by BTG Specialty Pharmaceuticals
|
Mar 04, 2022 |
Amputation for OS; Patient & Surgeon Perspectives sponsored by BTG Speciality Pharmaceuticals
|
Feb 25, 2022 |
Surgical Management of Pulmonary Metastases in People with Osteosarcoma - COG Trial
|
Feb 18, 2022 |
Human Trial for OST-HER2
|
Feb 11, 2022 |
Osteosarcoma Q&A with Dr. Peter Anderson and OsteoWarriors
|
Feb 04, 2022 |
Osteobites: Back to Activity, Rotationplasty
|
Dec 17, 2021 |
OsteoBites: Clinical Trials for Relapsed or Refractory Osteosarcoma - The OLIE Study and Beyond!
|
Nov 19, 2021 |
Encore, Testing & Research Directory
|
Nov 12, 2021 |
Real Talk: What it's really like and how WE feel about Osteosarcoma.
|
Nov 08, 2021 |
Planning for Dignity and What Matters Most to You
|
Oct 22, 2021 |
Let's Talk Fertility and Osteosarcoma
|
Sep 24, 2021 |
How "Hydroxychloroquine and "self-eating" works with Osteosarcoma.
|
Sep 17, 2021 |
Osteosarcoma Update from Dr. Huang - 2019 OutSmarting Osteosarcoma recipient
|
Sep 12, 2021 |
OsteoBites Welcomes Junior Board Members to discuss "Four OsteoWarriors' Perspectives".
|
Jul 30, 2021 |
OsteoBites welcomes Dr. Moyez Jiwa to discuss "The Art of Doctoring"
|
Jul 23, 2021 |
Osteosarcoma OsteoBites S2 Ep 18: Richard Gorlick, MD & Yifei Wang, MD “Antibody Drug Conjugates for Osteosarcoma”
|
Jun 24, 2021 |
Osteosarcoma OsteoBites S2 Ep 17: Lara Davis, MD, OHSU Knight Cancer Institute “New Osteosarcoma Clinical Trials”
|
Jun 17, 2021 |
Osteosarcoma OsteoBites S2 Ep 16: Julie Lanford, MPH, RD, CSO, LDN on “Nutrition & Cancer; Truths & Myths”
|
Jun 10, 2021 |
Osteosarcoma OsteoBites S2 Ep 15: Katie Greenzang, MD, EdM Dana-Farber CI & Harvard Med School “What’s Next? Survivorship"
|
May 20, 2021 |
Osteosarcoma OsteoBites S2 Ep 14: Lillian Guenther, MD Dana-Farber CI & Harvard Med School “CRISPR Screening to Identify Novel Genomic Targets"
|
May 13, 2021 |
Osteosarcoma OsteoBites S2 E13: Scott Sauer, PhD on “Preventing Osteosarcoma Lethal Recurrence by Targeting Disseminated Tumor Cells”
|
May 06, 2021 |
Osteosarcoma OsteoBites S2 Ep12: Dan Prince, MD, MPH on “Regenerative Surgery for Bone Sarcomas”
|
Apr 29, 2021 |
Osteosarcoma OsteoBites S2 Ep 11: Ines Lohse, PhD on “Drug Sensitivity Testing for the Treatment Stratification of Cancer Patients”
|
Apr 22, 2021 |
Osteosarcoma OsteoBites S2 Ep 10: Sumit Gupta, MD, PhD, FRCPC “Long Term Mental Health Outcomes in Adolescents and Young Adults with Cancer”
|
Apr 15, 2021 |
MIB Agents OsteoBites S2 Ep 9: Jane Yanagawa, MD, “Osteosarcoma Lung Metastases”
|
Apr 08, 2021 |
OsteoBites S2 Ep 8: Chand Khanna DVM, PhD, “A Comparative Approach To Metastasis: Biology and Therapy”
|
Apr 01, 2021 |
OsteoBites S2 Ep7: Corrie Painter, PhD “The Osteosarcoma Project, Patient-Partnered Research Update”
|
Mar 05, 2021 |
OsteoBites S2 Ep6: Brian Van Tine, MD, PhD on “Osteosarcoma Tumor Metabolism”
|
Feb 11, 2021 |
OsteoBites S2 Ep5: Robbie Majzner, MD on “Unleashing the Pediatric Immune System Against Osteosarcoma and Other Solid Tumors”
|
Feb 04, 2021 |
OsteoBites S3 Ep4: Lor Randall, MD, "Sarcomatology: A Trans-Disciplinary Approach"
|
Jan 29, 2021 |
OsteoBites S2 Ep3: Pete Anderson, MD, PhD "Understanding Lab, Path and Scan Reports and Other Questions Answered"
|
Jan 21, 2021 |
OsteoBites S2 Ep2: Alejandro Sweet Cordero, MD "Genome-Informed Targeted Therapies for Osteosarcoma"
|
Jan 14, 2021 |
OsteoBites S2 Ep1: Erin Murphy, Associate Professor, Radiation Oncology at Cleveland Clinic: Radiosurgery and SBRT for Sarcoma”
|
Jan 08, 2021 |
OsteoBites S1 Ep28: Ryan Roberts, MD, PhD. “Dear Lungs, Stop enabling this cancer: Targeting interactions that facilitate osteosarcoma metastasis.”
|
Nov 21, 2020 |
OsteoBites S1 Ep27: Brian Crompton, MD, “New Genomic Approaches to Understanding Osteosarcoma”
|
Nov 15, 2020 |
OsteoBites S1 Ep25: Sulagna Banerjee, PhD, “Modeling Osteosarcoma in Mice”
|
Oct 16, 2020 |
OsteoBites S1 Ep24: Andy Woods & Charles Keller, MD: "Legacy Autopsy”
|
Sep 25, 2020 |
Lauren: Osteosarcoma Survivor, Sibling of OsteoAngel and MIB Jr. Board Member
|
Sep 21, 2020 |
OsteoBites S1 Ep23: Brian Flesner, DVM, MS, DACVIM: "Adjuvant Chemotherapy for Canine Osteosarcoma ”
|
Sep 18, 2020 |
OsteoBites S1 Ep22: Reed: "Moffitt Osteosarcoma Research Approach”
|
Sep 10, 2020 |
OsteoBites S1 Ep21: Kurt Weiss, MD, A Day In the Life of a Musculoskeletal Oncologist
|
Aug 28, 2020 |
OsteoBites S1 Ep20: Correlative Science Leading to Active and Emerging Clinical Trials for #Osteosarcoma
|
Aug 21, 2020 |
OsteoBites S1 Ep19: Modeling & Targeting MYC-Driven Osteosarcoma
|
Aug 14, 2020 |
OsteoBites S1 Ep18: Coping Through Cancer: Tips for Parents & Caregivers
|
Aug 10, 2020 |
OsteoBites S1 Ep17: The #Osteosarcoma Patient Decision Aid for Surgical Options in the Lower Extremity
|
Jul 30, 2020 |
OsteoBites S1 Ep16: Peter Anderson, MD, PhD on Making It Better for OS Patients
|
Jul 23, 2020 |
OsteoBites S1 Ep15: Survivorship Care Planning with David Poplack, MD and Ellen Shohet, RN
|
Jul 17, 2020 |
OsteoBites S1 Ep14 Katie Janeway, MD, NEW Osteosarcoma Clinical Trial
|
Jul 10, 2020 |
OsteoBites S1 Ep12: John Healey, MD, Precision Surgery for Osteosarcoma
|
Jul 02, 2020 |
OsteoBites S1 Ep11: Alanna Church, MD and Christina Ip-Toma, MIB Testing & Research Directory
|
Jun 19, 2020 |
OsteoBites S1 Ep10: Simon Holland and Elly App
|
Jun 12, 2020 |
OsteoBites S1 Ep9: Amputee Coalition
|
Jun 04, 2020 |
OsteoBites S1 Ep8: Osteosarcoma Research, Joshua Schiffman, MD
|
May 28, 2020 |
OsteoBites S1 Ep7: Osteosarcoma Research, Matteo Trucco, MD
|
May 23, 2020 |
OsteoBites S1 Ep6: Osteosarcoma Research, J. Andrew Livingston, MD
|
May 14, 2020 |
OsteoBites S1 Ep5: Osteosarcoma Research, Alex Huang, MD, PhD of UH Rainbow Babies & Children's & CWRU
|
May 08, 2020 |
OsteoBites S1 EP2: Osteosarcoma Q&A with Matteo Trucco, MD of Cleveland Clinic
|
May 06, 2020 |
OsteoBites S1 Ep4: Upfront Surgery for Osteosarcoma, David Loeb, MD, PhD & Matteo Trucco, MD
|
May 02, 2020 |
OsteoBites: S1, EP3 Osteosarcoma Institute with Lee Helman, MD & Joyce Schaffer, RN
|
Apr 27, 2020 |